Standout Papers

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Meta... 2008 2026 2014 2020 703
  1. Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206 (2008)
    Brian I. Rini, Susan Halabi et al. Journal of Clinical Oncology

Immediate Impact

4 from Science/Nature 68 standout
Sub-graph 1 of 21

Citing Papers

Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
2023 Standout
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
2023 Standout
10 intermediate papers

Works of Laura Archer being referenced

Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer
2009
Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
2008 Standout

Author Peers

Author Last Decade Papers Cites
Laura Archer 521 852 102 530 27 1.5k
William C. Black 1019 629 40 221 34 2.2k
Serge Benayoun 381 1320 24 190 24 2.0k
Monique M.E.M. Bos 1068 659 13 518 36 2.1k
Cornelis T. Postma 148 1011 48 321 42 1.8k
Piotr Czaykowski 831 1183 23 786 88 2.1k
John Hohneker 1435 484 22 288 39 1.9k
A. Garin 763 1184 21 634 26 1.8k
Barry Meisenberg 828 174 45 293 64 1.8k
J. B. O'Connell 934 369 15 331 15 2.1k
Paul Blanche 306 545 35 425 61 1.9k

All Works

Loading papers...

Rankless by CCL
2026